@article{3174091,
    title = "Skin cancer screening: recommendations for data-driven screening
guidelines and a review of the US Preventive Services Task Force
controversy",
    author = "Johnson, Mariah M. and Leachman, Sancy A. and Aspinwall, Lisa G. and and Cranmer, Lee D. and Curiel-Lewandrowski, Clara and Sondak, Vernon K. and and Stemwedel, Clara E. and Swetter, Susan M. and Vetto, John and Bowles, and Tawnya and Dellavalle, Robert P. and Geskin, Larisa J. and Grossman, and Douglas and Grossmann, Kenneth F. and Hawkes, Jason E. and Jeter, Joanne and M. and Kim, Caroline C. and Kirkwood, John M. and Mangold, Aaron R. and and Meyskens, Frank and Ming, Michael E. and Nelson, Kelly C. and Piepkorn, and Michael and Pollack, Brian P. and Robinson, June K. and Sober, Arthur J. and and Trotter, Shannon and Venna, Suraj S. and Agarwala, Sanjiv and Alani, and Rhoda and Averbook, Bruce and Bar, Anna and Becevic, Mirna and Box, Neil and and Carson, III, William E. and Cassidy, Pamela B. and Chen, Suephy C. and and Chu, Emily Y. and Ellis, Darrel L. and Ferris, Laura K. and Fisher, and David E. and Kendra, Kari and Lawson, David H. and Leming, Philip D. and and Margolin, Kim A. and Markovic, Svetomir and Martini, Mary C. and Miller, and Debbie and Sahni, Debjani and Sharfman, William H. and Stein, Jennifer and and Stratigos, Alexander J. and Tarhini, Ahmad and Taylor, Matthew H. and and Wisco, Oliver J. and Wong, Michael K.",
    journal = "Melanoma Management",
    year = "2017",
    volume = "4",
    number = "1",
    pages = "13-37",
    publisher = "Future Medicine Ltd",
    issn = "2045-0885, 2045-0893",
    doi = "10.2217/mmt-2016-0022",
    keywords = "early detection; guidelines; keratinocyte carcinoma; melanoma; melanoma
odds ratio; melanoma relative risk; melanoma risk factors; screening;
skin cancer; USPSTF",
    abstract = "Melanoma is usually apparent on the skin and readily detected by trained
medical providers using a routine total body skin examination, yet this
malignancy is responsible for the majority of skin cancer-related
deaths. Currently, there is no national consensus on skin cancer
screening in the USA, but dermatologists and primary care providers are
routinely confronted with making the decision about when to recommend
total body skin examinations and at what interval.
The objectives of this paper are: to propose rational, risk-based,
data-driven guidelines commensurate with the US Preventive Services Task
Force screening guidelines for other disorders; to compare our proposed
guidelines to recommendations made by other national and international
organizations; and to review the US Preventive Services Task Force's
2016 Draft Recommendation Statement on skin cancer screening."
}